Dr Mark Dominic Corriere, MD in Columbia, MD - Medicare Endocrinology

Dr Mark Dominic Corriere, MD is a medicare enrolled "Internal Medicine" physician in Columbia, Maryland. He went to Washington University School Of Medicine and graduated in 1996 and has 28 years of diverse experience with area of expertise as Endocrinology. He is a member of the group practice Maryland Endocrine, P.a. and his current practice location is 10710 Charter Dr, Suite 410, Columbia, Maryland. You can reach out to his office (for appointments etc.) via phone at (301) 953-2080.

Dr Mark Dominic Corriere is licensed to practice in Maryland (license number D57817) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1053350843.

Contact Information

	Dr Mark Dominic Corriere, MD
	10710 Charter Dr, Suite 410, Columbia, MD 21044-3128
	(301) 953-2080
	(301) 953-3543

Physician's Profile

Full Name	Dr Mark Dominic Corriere
Gender	Male
Speciality	Endocrinology
Experience	28 Years
Location	10710 Charter Dr, Columbia, Maryland
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Dr Mark Dominic Corriere attended and graduated from Washington University School Of Medicine in 1996

NPI Data:

NPI Number: 1053350843
Provider Enumeration Date: 06/06/2006
Last Update Date: 06/17/2014

Medicare PECOS Information:

PECOS PAC ID: 6204025943
Enrollment ID: I20110111000329

Medical Identifiers

Medical identifiers for Dr Mark Dominic Corriere such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1053350843	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207R00000X	Internal Medicine	D57817 (Maryland)	Primary

Medical Facilities Affiliation

Facility Name	Location	Facility Type
Johns Hopkins Hospital, The	Baltimore, MD	Hospital

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
Maryland Endocrine, P.a.	4082659529	10

News Archive

Scientists propose new framework to assess innovative nicotine and tobacco products

Scientists at British American Tobacco have proposed a new scientific framework that could be used to assess the reduced-risk promise of the myriad of innovative nicotine and tobacco products currently being developed.

NCPA applauds pharmacy tricare provisions in the congressional passage of the defense authorization bill

The National Community Pharmacists Association (NCPA) thanks Congress for including key pharmacy provisions in the Defense Authorization Act Conference Report for fiscal year 2008 it passed last week.

Onyx, Bayer initiate patient enrollment in Nexavar Phase 3 trial for breast cancer treatment

Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals, Inc. today announced the companies have begun enrolling patients in a Phase 3 randomized, double-blind, placebo-controlled trial evaluating Nexavar tablets in combination with the oral chemotherapeutic agent, capecitabine, versus placebo plus capecitabine for the treatment of patients with advanced breast cancer.

Shire completes aquisition of New River

Shire plc has announced that it has completed its acquisition of New River Pharmaceuticals Inc.

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Mark Dominic Corriere allows following entities to bill medicare on his behalf.

Entity Name	Maryland Endocrine, P.a.
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1316913486 PECOS PAC ID: 4082659529 Enrollment ID: O20050624000242

News Archive

Scientists propose new framework to assess innovative nicotine and tobacco products

NCPA applauds pharmacy tricare provisions in the congressional passage of the defense authorization bill

Onyx, Bayer initiate patient enrollment in Nexavar Phase 3 trial for breast cancer treatment

Shire completes aquisition of New River

Shire plc has announced that it has completed its acquisition of New River Pharmaceuticals Inc.

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Mark Dominic Corriere is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Mark Dominic Corriere, MD 10710 Charter Dr, Suite 410, Columbia, MD 21044-3128 Ph: (301) 953-2080	Dr Mark Dominic Corriere, MD 10710 Charter Dr, Suite 410, Columbia, MD 21044-3128 Ph: (301) 953-2080

News Archive

Scientists propose new framework to assess innovative nicotine and tobacco products

NCPA applauds pharmacy tricare provisions in the congressional passage of the defense authorization bill

Onyx, Bayer initiate patient enrollment in Nexavar Phase 3 trial for breast cancer treatment

Shire completes aquisition of New River

Shire plc has announced that it has completed its acquisition of New River Pharmaceuticals Inc.

Internal Medicine Doctors in Columbia, MD

Dr. Jon Kent Minford, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 10710 Charter Dr, Suite G020, Columbia, MD 21044 Phone: 410-964-2212 Fax: 410-964-0380
Dr. Jacob Cherian, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 5450 Knoll North Dr, Columbia, MD 21045 Phone: 410-964-5311 Fax: 410-964-8578
Dr. Tejaswi Rajasekhara Sastry, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 10710 Charter Dr, Suite G020, Columbia, MD 21044 Phone: 410-964-2212 Fax: 410-964-0380
Michael Howard Kelemen, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 5450 Knoll North Dr, Suite 200b, Columbia, MD 21045 Phone: 410-964-5303
Dr. Tin O Maung, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 5999 Harpers Farm Rd, Suite W250, Columbia, MD 21044 Phone: 410-772-8822 Fax: 410-772-9274
Dr. Jeffery Wayne Van Den Broek, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 10710 Charter Dr, Suite 110, Columbia, MD 21044 Phone: 410-992-9797 Fax: 410-730-0942
Angela M. Kopack, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 11055 Little Patuxent Pkwy, Suite 209, Columbia, MD 21044 Phone: 410-884-1311 Fax: 410-884-6033

Dr Mark Dominic Corriere, MD - Medicare Endocrinology in Columbia, MD

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medical Facilities Affiliation

Group Practice Association

Scientists propose new framework to assess innovative nicotine and tobacco products

NCPA applauds pharmacy tricare provisions in the congressional passage of the defense authorization bill

Onyx, Bayer initiate patient enrollment in Nexavar Phase 3 trial for breast cancer treatment

Shire completes aquisition of New River

Medicare Reassignments

Scientists propose new framework to assess innovative nicotine and tobacco products

NCPA applauds pharmacy tricare provisions in the congressional passage of the defense authorization bill

Onyx, Bayer initiate patient enrollment in Nexavar Phase 3 trial for breast cancer treatment

Shire completes aquisition of New River

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

Scientists propose new framework to assess innovative nicotine and tobacco products

NCPA applauds pharmacy tricare provisions in the congressional passage of the defense authorization bill

Onyx, Bayer initiate patient enrollment in Nexavar Phase 3 trial for breast cancer treatment

Shire completes aquisition of New River

Internal Medicine Doctors in Columbia, MD